Holen Sie sich die Stockscreener-App
14.91
1.34%
-0.22
Schlusskurs vom Vortag:
$15.13
Offen:
$14.86
24-Stunden-Volumen:
841.92K
Relative Volume:
0.31
Marktkapitalisierung:
$2.67B
Einnahmen:
$15.36M
Nettoeinkommen (Verlust:
$-276.48M
KGV:
-9.2442
EPS:
-1.6129
Netto-Cashflow:
$-235.87M
1W Leistung:
-8.98%
1M Leistung:
+55.49%
6M Leistung:
+102.26%
1J Leistung:
+366.46%
1-Tages-Spanne:
$14.80
$15.40
1-Wochen-Bereich:
$14.68
$17.15
52-Wochen-Spanne:
$2.6701
$17.32
Relay Therapeutics Inc Stock (RLAY) Company Profile
Firmenname
Relay Therapeutics Inc
Sektor
Branche
Telefon
617-370-8837
Adresse
60 HAMPSHIRE STREET, CAMBRIDGE
Compare RLAY vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
14.94 | 2.70B | 15.36M | -276.48M | -235.87M | -1.6129 |
VRTX
Vertex Pharmaceuticals Inc
|
431.37 | 109.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.51 | 79.46B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
794.38 | 48.52B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
311.12 | 40.77B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
301.49 | 33.39B | 5.36B | 287.73M | 924.18M | 2.5229 |
Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-26 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-12-12 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-09-04 | Fortgesetzt | Guggenheim | Buy |
| 2025-04-17 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-09-10 | Fortgesetzt | Goldman | Buy |
| 2024-09-10 | Hochstufung | Jefferies | Hold → Buy |
| 2024-09-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-05-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-04-20 | Hochstufung | Jefferies | Underperform → Hold |
| 2023-04-19 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | Eingeleitet | Raymond James | Outperform |
| 2023-02-03 | Eingeleitet | Oppenheimer | Outperform |
| 2022-09-30 | Eingeleitet | Barclays | Equal Weight |
| 2022-09-02 | Eingeleitet | Stifel | Buy |
| 2022-06-06 | Eingeleitet | Jefferies | Underperform |
| 2022-02-01 | Eingeleitet | Berenberg | Buy |
| 2021-07-21 | Eingeleitet | BofA Securities | Buy |
| 2020-12-15 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-11-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-08-10 | Eingeleitet | Cowen | Outperform |
| 2020-08-10 | Eingeleitet | Goldman | Buy |
| 2020-08-10 | Eingeleitet | Guggenheim | Buy |
| 2020-08-10 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Relay Therapeutics Inc Aktie (RLAY) Neueste Nachrichten
Breast cancer combo posts 44% response in pretreated patients - Stock Titan
Relay Therapeutics Announces Clinical Data for Zovegalisib - GlobeNewswire
Relay Therapeutics (RLAY) surges 16.4%: Is this an indication of further gains? - MSN
Industry Analysts Just Upgraded Their Relay Therapeutics, Inc. (NASDAQ:RLAY) Revenue Forecasts By 57% - Moomoo
RLAY SEC FilingsRelay Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
RLAY PE Ratio & Valuation, Is RLAY Overvalued - Intellectia AI
Relay Therapeutics (RLAY) Stock: Is It a Good Buy | Q4 2025: EPS Beats ForecastsReal-time Trade Ideas - UBND thành phố Hải Phòng
Is Relay Therapeutics (RLAY) stock strengthening its trend | Q4 2025: EPS Beats ForecastsCommunity Buy Alerts - Cổng thông tin điện tử Tỉnh Sơn La
JonesResearch Initiates Coverage of Relay Therapeutics with Hold Rating - HarianBasis.co
Relay Therapeutics (RLAY) climbs 16% ahead of cancer treatment update - MSN
Is Relay Therapeutics (RLAY) stock gaining momentum (Mini Selloff) 2026-04-20Fast Moving Stocks - Xã Vĩnh Công
JonesResearch Initiates Coverage of Relay Therapeutics (RLAY) With a Hold Rating - Insider Monkey
Relay Therapeutics (RLAY) Stock: Stability Assessment (Buying Pressure) 2026-04-18Intraday Trading - Cổng thông tin điện tử Tỉnh Sơn La
5 Best Low Priced Biotech Stocks to Invest In - Insider Monkey
Tudor Investment Corp ET AL Acquires New Shares in Relay Therapeutics, Inc. $RLAY - MarketBeat
PERCEPTIVE ADVISORS LLC Significantly Reduces Stake in Relay The - GuruFocus
[PRE 14A] Relay Therapeutics, Inc. Preliminary Proxy Statement - Stock Titan
Jones Trading initiates coverage of Relay Therapeutics (RLAY) with hold recommendation - MSN
Relay Therapeutics (NASDAQ:RLAY) Sets New 1-Year HighShould You Buy? - MarketBeat
RLAY Initiated Coverage by Jones Trading -- Rating Set to Hold - GuruFocus
JonesTrading Initiates Coverage on Relay Therapeutics (NASDAQ:RLAY) - MarketBeat
Perceptive Fund (RLAY) reports 9.99% ownership — 438,471 shares - Stock Titan
Will Relay Therapeutics (RLAY) Stock Recover Soon | Price at $15.21, Up 1.81%Price Target - UBND thành phố Hải Phòng
Relay Therapeutics CFO Sells $27,000 in Stock - National Today
Relay Therapeutics CFO Sells $27,000 in Shares - National Today
Relay Therapeutics stock hits 52-week high at 14.98 USD By Investing.com - Investing.com Canada
Relay Therapeutics Hits New 52-Week High After Analyst Upgrade - National Today
Earnings Recap: Will Relay Therapeutics Inc benefit from green energy policies2026 Action & Reliable Entry Point Alerts - baoquankhu1.vn
Catinazzo, Relay Therapeutics CFO, sells $257k in RLAY stock By Investing.com - Investing.com Australia
Catinazzo, Relay Therapeutics CFO, sells $257k in RLAY stock - Investing.com
Thomas Catinazzo Sells 1,800 Shares of Relay Therapeutics (NASDAQ:RLAY) Stock - MarketBeat
Relay Therapeutics (NASDAQ: RLAY) CFO logs 19,517-share sale under 10b5-1 plan - Stock Titan
Rally Mode: Will Relay Therapeutics Inc benefit from government policyRate Cut & Step-by-Step Swing Trade Plans - baoquankhu1.vn
Relay Therapeutics stock hits 52-week high at 14.98 USD - Investing.com
Relay Therapeutics (NASDAQ:RLAY) CFO Sells $230,498.17 in Stock - MarketBeat
Barclays Raises Price Target for Relay Therapeutics (RLAY) to $2 - GuruFocus
Finanzdaten der Relay Therapeutics Inc-Aktie (RLAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Relay Therapeutics Inc-Aktie (RLAY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Catinazzo Thomas | Chief Financial Officer |
Apr 07 '26 |
Sale |
13.01 |
17,717 |
230,498 |
213,867 |
| Catinazzo Thomas | Chief Financial Officer |
Apr 09 '26 |
Sale |
15.00 |
1,800 |
27,000 |
213,867 |
| Catinazzo Thomas | Chief Financial Officer |
Mar 09 '26 |
Sale |
10.06 |
17,717 |
178,233 |
231,584 |
0.03%
0.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):